Annals of Oncology

In this Issue:

Ann Oncol 16: 1563; doi:10.1093/annonc/mdi327
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Editorials:

P. Boyle and C. Dresler

Preventing the lung cancer epidemic
Ann Oncol 16: 1565-1566; doi:10.1093/annonc/mdi328
[Extract] [FREE Full Text] [PDF] [Request Permissions]

V. Raina

Doing cancer trials in India: opportunities and pitfalls
Annals of Oncology Advance Access published on July 8, 2005
Ann Oncol 16: 1567-1568; doi:10.1093/annonc/mdi315
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

A. Goldhirsch, J. H. Glick, R. D. Gelber, A. S. Coates, B. Thürlimann, and H.-J. Senn and Panel Members

Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
Annals of Oncology Advance Access published on September 7, 2005
Ann Oncol 16: 1569-1583; doi:10.1093/annonc/mdi326
[Abstract] [FREE Full Text] [PDF] [CME/CE] [Request Permissions]

A. Engert

Recombinant human erythropoietin in oncology: current status and further developments
Annals of Oncology Advance Access published on June 15, 2005
Ann Oncol 16: 1584-1595; doi:10.1093/annonc/mdi307
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Epidemiology:

C. Bosetti, F. Levi, F. Lucchini, E. Negri, and C. La Vecchia

Lung cancer mortality in European women: recent trends and perspectives
Annals of Oncology Advance Access published on July 13, 2005
Ann Oncol 16: 1597-1604; doi:10.1093/annonc/mdi313
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Hu, C. Galeone, R. Lui, C. Pelucchi, C. La Vecchia, and E. Negri

Smoking and lung cancer in Harbin, northeast China
Annals of Oncology Advance Access published on July 8, 2005
Ann Oncol 16: 1605-1608; doi:10.1093/annonc/mdi312
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

O. Pagani, C. Sessa, F. Nolè, E. Munzone, D. Crivellari, D. Lombardi, B. Thürlimann, D. Hess, R. Graffeo, M. Ruggeri, S. Longhi, and A. Goldhirsch

Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer
Annals of Oncology Advance Access published on June 30, 2005
Ann Oncol 16: 1609-1617; doi:10.1093/annonc/mdi308
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

U. Güth, G. Singer, A. Schötzau, I. Langer, H. Dieterich, C. Rochlitz, L. Herberich, W. Holzgreve, and E. Wight

Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey
Annals of Oncology Advance Access published on July 20, 2005
Ann Oncol 16: 1618-1623; doi:10.1093/annonc/mdi319
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

P. Schmid, J. Krocker, C. Jehn, K. Michniewicz, S. Lehenbauer-Dehm, H. Eggemann, V. Heilmann, S. Kümmel, C. O. Schulz, A. Dieing, M. B. Wischnewsky, S. Hauptmann, D. Elling, K. Possinger, and B. Flath

Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial
Annals of Oncology Advance Access published on July 19, 2005
Ann Oncol 16: 1624-1631; doi:10.1093/annonc/mdi321
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. Banerjee, I. E. Smith, L. Folkerd, J. Iqbal, P. Barker, and M. Dowsett On behalf of the IMPACT trialists

Comparative effects of anastrozole, tamoxifen alone and in combination on plasma lipids and bone-derived resorption during neoadjuvant therapy in the impact trial
Annals of Oncology Advance Access published on July 19, 2005
Ann Oncol 16: 1632-1638; doi:10.1093/annonc/mdi322
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

H. Oettle, D. Richards, R. K. Ramanathan, J. L. van Laethem, M. Peeters, M. Fuchs, A. Zimmermann, W. John, D. Von Hoff, M. Arning, and H. L. Kindler

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
Annals of Oncology Advance Access published on August 8, 2005
Ann Oncol 16: 1639-1645; doi:10.1093/annonc/mdi309
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. L. Westra, H. Hollema, M. Schaapveld, I. Platteel, K. A. Oien, W. N. Keith, R. Mauritz, G. J. Peters, C. H. C. M. Buys, R. M. W. Hofstra, and J. Th. M. Plukker

Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients
Annals of Oncology Advance Access published on July 12, 2005
Ann Oncol 16: 1646-1653; doi:10.1093/annonc/mdi316
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. R. Alberts, N. R. Foster, R. F. Morton, J. Kugler, P. Schaefer, M. Wiesenfeld, T. R. Fitch, P. Steen, G. P. Kim, and S. Gill

PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study
Annals of Oncology Advance Access published on August 5, 2005
Ann Oncol 16: 1654-1661; doi:10.1093/annonc/mdi324
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

S. Novello, C. Fava, P. Borasio, L. Dogliotti, G. Cortese, B. Crida, G. Selvaggi, P. Lausi, M. P. Brizzi, P. Sperone, L. Cardinale, F. Ferraris, F. Perotto, A. Priola, and G. V. Scagliotti

Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers
Annals of Oncology Advance Access published on July 8, 2005
Ann Oncol 16: 1662-1666; doi:10.1093/annonc/mdi314
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

M. Biscardi, R. Caporale, F. Balestri, S. Gavazzi, J. Jimeno, and A. Grossi

VEGF inhibition and cytotoxic effect of aplidin in leukemia cell lines and cells from acute myeloid leukemia
Annals of Oncology Advance Access published on July 13, 2005
Ann Oncol 16: 1667-1674; doi:10.1093/annonc/mdi311
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Ghielmini, K. Rufibach, G. Salles, L. Leoncini-Franscini, C. Léger-Falandry, S. Cogliatti, M. Fey, G. Martinelli, R. Stahel, A. Lohri, N. Ketterer, M. Wernli, T. Cerny, and S.-F. Hsu Schmitz

Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)
Annals of Oncology Advance Access published on July 19, 2005
Ann Oncol 16: 1675-1682; doi:10.1093/annonc/mdi320
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

L. Nogová, T. Reineke, H. T. Eich, A. Josting, H. K. Müller-Hermelink, K. Wingbermühle, C. Brillant, A. Gossmann, J. Oertel, M. V. Bollen, R.-P. Müller, V. Diehl, and A. Engert for the GHSG

Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG)
Annals of Oncology Advance Access published on August 10, 2005
Ann Oncol 16: 1683-1687; doi:10.1093/annonc/mdi323
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

M. Moore, H. W. Hirte, L. Siu, A. Oza, S. J. Hotte, O. Petrenciuc, F. Cihon, C. Lathia, and B. Schwartz

Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors
Annals of Oncology Advance Access published on July 8, 2005
Ann Oncol 16: 1688-1694; doi:10.1093/annonc/mdi310
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. H. G. Hansma, H. J. Broxterman, I. van der Horst, Y. Yuana, E. Boven, G. Giaccone, H. M. Pinedo, and K. Hoekman

Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer
Annals of Oncology Advance Access published on July 12, 2005
Ann Oncol 16: 1695-1701; doi:10.1093/annonc/mdi318
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Brain tumors:

G. Dresemann

Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series
Annals of Oncology Advance Access published on July 20, 2005
Ann Oncol 16: 1702-1708; doi:10.1093/annonc/mdi317
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters:

N. Normanno, M. Campiglio, F. Perrone, A. De Luca, and S. Menard

Is the gefitinib plus trastuzumab combination feasible in breast cancer patients?
Annals of Oncology Advance Access published on September 8, 2005
Ann Oncol 16: 1709; doi:10.1093/annonc/mdi325
[Extract] [FREE Full Text] [PDF] [Request Permissions]

P. F. Ferrucci, A. Vanazzi, G. Tesoriere, M. Ferrari, M. Bartolomei, P. Rocca, M. Cremonesi, G. Paganelli, and G. Martinelli

Cerebrospinal fluid diffusion of Zevalin^® after high-activity treatment and stem cell support in a patient affected by diffuse large B-cell non-Hodgkin's lymphoma with central nervous system involvement
Annals of Oncology Advance Access published on June 21, 2005
Ann Oncol 16: 1710-1711; doi:10.1093/annonc/mdi305
[Extract] [FREE Full Text] [PDF] [Request Permissions]

O. Bouché, H. Brixi-Benmansour, A. Bertin, G. Perceau, and S. Lagarde

Trichomegaly of the eyelashes following treatment with cetuximab
Annals of Oncology Advance Access published on June 21, 2005
Ann Oncol 16: 1711-1712; doi:10.1093/annonc/mdi300
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. K. Nowak and M. J. Byrne

Cisplatin and gemcitabine in malignant mesothelioma
Annals of Oncology Advance Access published on July 6, 2005
Ann Oncol 16: 1711; doi:10.1093/annonc/mdi303
[Extract] [FREE Full Text] [PDF] [Request Permissions]

T. Tanvetyanon

Reply to the article "The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer" by K. P. Weinfurt et al. (Ann Oncol 2005; 16: 579–584)
Annals of Oncology Advance Access published on June 21, 2005
Ann Oncol 16: 1712-1713; doi:10.1093/annonc/mdi301
[Extract] [FREE Full Text] [PDF] [Request Permissions]

L. Gianni, M. Colleoni, J. F. Golding, and A. Goldhirsch

Can tamoxifen relieve motion sickness?
Annals of Oncology Advance Access published on July 8, 2005
Ann Oncol 16: 1713-1714; doi:10.1093/annonc/mdi304
[Extract] [FREE Full Text] [PDF] [Request Permissions]

P. Chalasani, M. Vohra, and J. N. Sheagren

An association of sarcoidosis with hepatocellular carcinoma
Annals of Oncology Advance Access published on June 21, 2005
Ann Oncol 16: 1714-1715; doi:10.1093/annonc/mdi306
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.